Cosmo Pharmaceuticals N.V. (COPN.SW) Deep Dive Video
Summary
Cosmo has reinvented itself into a recurring-revenue AI-and-dermatology platform—GI Genius and Winlevi are scaling, the balance sheet is fortress-like, and Vision 2030 is the operating-leverage payoff.